Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Healius Limited ( (AU:HLS) ) has provided an update.
Healius Limited announced that Perpetual Limited and its related bodies corporate have ceased to be substantial holders in the company as of May 27, 2025. This change in shareholding could impact Healius’s market dynamics and stakeholder relationships, as substantial holders often influence company decisions and strategic directions.
The most recent analyst rating on (AU:HLS) stock is a Hold with a A$1.65 price target. To see the full list of analyst forecasts on Healius Limited stock, see the AU:HLS Stock Forecast page.
More about Healius Limited
Healius Limited operates in the healthcare industry, providing medical and diagnostic services across Australia. The company focuses on delivering accessible and quality healthcare services, including pathology, imaging, and day hospital services.
Average Trading Volume: 3,161,629
Technical Sentiment Signal: Sell
Current Market Cap: A$642.6M
See more data about HLS stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue